| abstract |
The present invention provides a tablet, wherein the stability of active ingredients (potassium ion competitive acid blocker and acetyl salicyclic acid) is high, and the pharmacological effect of the active ingredients after administration can be expressed stably and rapidly. n n The tablet of the present invention is tablet having inner core and outer layer, wherein the inner core is an enteric coated tablets containing acetyl salicyclic acid, and the outer layer contains non-enteric coated potassium ion competitive acid blocker. |